基本信息
views: 66

Bio
Research Statement:
Dr. Jim Hu's major research goal is to develop novel gene delivery strategies in order to translate the genetic discoveries into clinical applications. His team developed novel viral vectors that can protect CF mice from acute lung bacterial infection and established methods for efficient airway gene delivery to large animals. His current endeavour is to achieve permanent airway gene correction by targeting the airway stem cells.
Dr. Jim Hu is presently a Senior Scientist in the Physiology & Experimental Medicine Program at the Research Institute at The Hospital for Sick Children (SickKids). He is also a Professor in the Departments of Laboratory Medicine and Pathobiology and Paediatrics, and is a member of the Graduate Faculty of the Institute of Medical Science, University of Toronto. He is currently a member of the University of Toronto Graduate Education Council (2014-2017).
His PhD studies on RNA polymerase and gene transcription were carried out under the supervision of Dr. Lawrence Bogorad in the Department of Cellular and Developmental Biology. After graduating, Dr. Hu came to SickKids for his postdoctoral training in RNA splicing with Dr. James D. Friesen in the Department of Genetics.
Dr. Hu serves as a member of the American Society of Gene Therapy Genetic Diseases Committee (2007-2010), and a member of the Medical/Scientific Advisory Committee of the Canadian Cystic Fibrosis Foundation and Chair of its Research Subcommittee (2006-2009). He has served as a panel member for the CIHR Respiratory Committee and for the Canadian Lung Association several times. He also served as a grant panel member for the National Science Foundation of China several times.
Dr. Jim Hu's major research goal is to develop novel gene delivery strategies in order to translate the genetic discoveries into clinical applications. His team developed novel viral vectors that can protect CF mice from acute lung bacterial infection and established methods for efficient airway gene delivery to large animals. His current endeavour is to achieve permanent airway gene correction by targeting the airway stem cells.
Dr. Jim Hu is presently a Senior Scientist in the Physiology & Experimental Medicine Program at the Research Institute at The Hospital for Sick Children (SickKids). He is also a Professor in the Departments of Laboratory Medicine and Pathobiology and Paediatrics, and is a member of the Graduate Faculty of the Institute of Medical Science, University of Toronto. He is currently a member of the University of Toronto Graduate Education Council (2014-2017).
His PhD studies on RNA polymerase and gene transcription were carried out under the supervision of Dr. Lawrence Bogorad in the Department of Cellular and Developmental Biology. After graduating, Dr. Hu came to SickKids for his postdoctoral training in RNA splicing with Dr. James D. Friesen in the Department of Genetics.
Dr. Hu serves as a member of the American Society of Gene Therapy Genetic Diseases Committee (2007-2010), and a member of the Medical/Scientific Advisory Committee of the Canadian Cystic Fibrosis Foundation and Chair of its Research Subcommittee (2006-2009). He has served as a panel member for the CIHR Respiratory Committee and for the Canadian Lung Association several times. He also served as a grant panel member for the National Science Foundation of China several times.
Research Interests
Papers共 177 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
biorxiv(2025)
FRONTIERS IN IMMUNOLOGY (2024)
Genes & Diseasesno. 4 (2023): 1131-1132
Cited0Views0Bibtex
0
0
Load More
Author Statistics
#Papers: 177
#Citation: 5575
H-Index: 42
G-Index: 67
Sociability: 6
Diversity: 4
Activity: 12
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn